Aspectos destacados y características
What is happening at Real-World Evidence Conference
Need Approval in Order to Attend?
Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.
- Gain a comprehensive understanding of the latest advancements and regulatory updates in RWE from leading experts in the field
- Engage with industry leaders, regulatory authorities, and peers to discuss innovative strategies and practical applications in RWE
- Explore diverse use cases and methodological insights across early development, late-phase, and post-marketing scenarios to enhance your knowledge and practice
- Discover cutting-edge technologies and operational strategies that are shaping the future of RWE generation
- Examine the intersection of AI and RWE, and discuss the implications for policy and regulatory frameworks
- Stay at the forefront of real-world evidence (RWE) with the latest advancements, regulatory updates, and practical applications from leading experts and key industry players
- Deep dive into various stages of drug development, from early-phase studies to post-marketing safety, and understand how RWE is applied across different use cases
- Learn about the latest methodological approaches and innovations in RWE, including causal methods, negative control outcomes, and sensitivity analyses
- Discover new technologies and operational strategies that enhance RWE generation, such as AI-enabled data abstraction and data linkage techniques
- Explore strategies to address health equity and improve diversity in drug development, leveraging RWE to build more representative and inclusive study populations
- Gain insights into international regulatory perspectives and practical challenges in using RWE, and learn how to balance data innovation with scientific rigor
- Understand how artificial intelligence is transforming clinical study designs and policy frameworks, and explore the future intersection of AI and RWE in pharmacoepidemiology
Complimentary Solution Provider Webinar: Raising the Bar on Real-world Data Quality: Ensuring Regulatory-grade EHR Data
September 18 - 1:00-1:45PM
Join Truveta’s Chief Medical Officer and VP of Product Management, Michael Simonov, for a webinar on a rigorous approach to data quality. We’ll highlight key questions to consider when evaluating whether a dataset is fit for purpose and audit-ready for regulatory submissions. We’ll also discuss how our unique relationship with 30 US health systems and our use of cutting-edge AI is accelerating real-world evidence generation using EHR data including for regulatory purposes.
Short Course: How Good is Good Enough? Fit-for-Purpose Considerations for RWD/RWE for Regulatory Purposes
October 15, 2024 – 10:00AM ET – 2:00PM ET | Virtual
*Short Courses require an additional registration fee. You do not need to be registered for the forum to attend*
Back by popular demand, this short course will describe the myriad of factors that scientists and other stakeholders should consider when determining whether – and how – to use real-world evidence (RWE) and select proper real world databases (RWD) to support regulatory submissions to the United States Food and Drug Administration (US FDA). This course will interpret and apply recent draft guidance documents related to RWE issued by the US FDA and use case studies – both successful and unsuccessful – to highlight key learnings. We will also review common biases and proper exposure definitions when conducting RWE studies.
Receive $150 off your forum registration by registering for any combination of at least two short courses and/or primers as well as the main forum. Purchases must be made at the same time to receive the discount. Discounts will be reflected on the last page of the cart.
Short Course: Integrated Evidence Generation Planning: A Robust Approach to Maximize the Impact of RWE for Healthcare Decision-makers
October 16, 2024 – 10:00AM ET – 2:00PM ET | Virtual
*Short Courses require an additional registration fee. You do not need to be registered for the forum to attend*
In this short course we will educate delegates with key learnings, case studies and guidance in best practice for delivering IEGP in the biopharmaceutical industry. The course will combine short presentations, Q&A sessions and interactive workshop exercises to deliver an engaging and informative course on this increasingly important initiative.
Receive $150 off your forum registration by registering for any combination of at least two short courses and/or primers as well as the main forum. Purchases must be made at the same time to receive the discount. Discounts will be reflected on the last page of the cart.
Media Partner: The Evidence Base
The Evidence Base is a free-to-access website providing the latest news, opinion and insight into hot topics including real-world data, health economics and outcomes research and patient-centric care. By registering on the site, users can access premium content and receive tailored newsletters, helping them to stay up-to-date with the field.
¿Tiene una cuenta?